Prof Louis Niessen
Professor of Public Health Economics / Public Health Modelling
| Job Title | Contact | Location |
|---|---|---|
|
Professor
of Public Health Economics / Public Health Modelling |
L dot Niessen at uea dot ac dot uk
Tel: 7178/1641 |
Medical School 2.23 |
Career
| University of Groningen, Population Research Centre / Erasmus U Rotterdam, Dept of Health Policy and Management. | PhD | 2001 | Health Economic & Demographic Modeling (Rutten / Willekens) |
| Netherlands School of Public Health | 1996 | Registrar training in Public Health | |
| Vrije University Amsterdam | MSc | 1992 | Epidemiology |
| London Schools of Economics & Political Science and London School of Hygiene & Tropical Medicine | MSc | 1987 | Health Planning & Financing |
| ErasmusMC, Erasmus University Rotterdam | MD | 1981 | Medicine |
| Medical Licensure | |
| 1996-now | Public Health Specialist; Registry Royal Dutch Society of Medicine; License SGRC no: AIS 1382539. Extended after review: 2001, 2006. |
| 1997-now | Public Health Specialist License; Registry Chief Medical Officer, the Netherlands; BIG 990229799014. |
| 1987-1990 | General Medical License, Medical Council London 3218592 |
| 1981-now | Medical License; Registry Chief Medical Officer, the Netherlands; BIG 99022979901 |
Other Certification |
|
| 1993-now | Epidemiologist Registration; Netherlands Epidemiological Society Federation of Medical Science Associations. |
Research interests
To contribute to population health through quantitative and qualitative research in health sciences and through evidence-based contributions to national and local health policy making.
Personal statement on professional qualifications
- Broad international & methodological experience in health economics, health services and system research combining areas in economics, evidence for health practice, formulation of health packages.
- Expert in specific applied health areas: sector-wide allocation, quantitative analyses, reimbursement decisions, and guidelines, cluster-RCTs in hepatitis, lung health, diabetes, stroke, cardiovascular diseases and child health.
- Broad health policy experience at national level with health policy makers, applied researchers and professional societies, using both qualitative and quantitative methods
- Broad practical experience in local health program organization in various countries.
Career summary
| 2008 - now | School of Health, Health Policy and Practice, University of East Anglia, UK Professor Public Health Economics & Public Health Modelling (public health, chronic diseases) |
| 2008 - now | Division Health Systems, Department of International Health, Johns Hopkins School of Public Health, Associate Professor (public health, economics, international health, chronic infectious diseases) |
| 1997-2007 | Institutes of Health Policy and Management and Medical Technology Assessment, Erasmus University Rotterdam. Member Management Team and Program Leader International Health Research, Project leader research projects. Lecturer Master courses. |
| 2001 all/winter | WHO, GPE/EIP group; sector level economic evaluation. Senior advisor (P5) on university UN -leave of absence. Health modeling for World Health Report 2002, Reducing risks, promoting healthy life. |
| 1996-1997 | Dutch National Institute for Public Health, Centre Public Health Forecasting; program leader, macro-modeling health care. |
| 1993-1996 | Dutch National Institute for Public Health, Centre for International Forecasts; program leader, international health projections. |
| 1991-1992 | Erasmus University Rotterdam, Public Health Department: researcher integrated disease modeling |
| 1987-1991 | Dept of Health Services, MoH, Nepal; senior advisor / consultant / project leader, MoH, WHO, UNFPA for district programmes, Eastern Region. Primary and hospital care, and health worker training programs. |
| 1984-1986 | MoH, Peru Regional Primary Care Services, ; clinician, advisor / project leader, provincial health programs in the Amazon jungle. Various indigenous groups. Health clinics and primary care training programs. |
| 1981-1983 | NVTG Generalist Training, medical residencies: chest diseases, obstetrics, surgery, internal medicine, and pediatrics. Rubya Hospital, MoH, Tanzania GeneralDutch hospitals and in Rotterdam, Schiedam, and Gouda. |
Website
Key Research Interests
A review project “Economic Evaluation as part of Systematic Review, funded by the US Agency of Health Research and Quality with USD 240,000. Dr. Niessen is co-PI responsible for the international comparative component. The project is starting in September 2008.
A WHO-funded project “Health worker effectiveness in child health” of USD 100,000 to model the health worker effectiveness for child survival. The PI is Dr. Niessen with Erasmus U, JHSPH and the Dutch Royal Tropical Institute as participants. The project is starting in December 2008.
A GSK-funded project “Economic Positioning of Malaria Vaccines” of USD 140,000 to review existing economic malaria models and to develop a new model. The PI is Dr. Niessen. It has started in 2007 and is ongoing with Erasmus U and JHSPH participating. A follow-up project is planned to evaluate the malaria vaccine in five countries.
The Dutch Environmental Assessment Agency funded the project “Integrated Health Modeling” of USD 180,000 to support international reporting for UNEP and other UN agencies. The model has been applied for the WHO/UNICEF GAPP initiative to evaluate preventive interventions, immunizations and case management to reduce the pneumonia burden. Dr. Niessen is the PI. Duration: 2006-2008.
The Dutch MoH funded the project “Welfare effects of affluent diseases” and is carried out by Erasmus with Dutch National Planning Office (CPB), Netherlands. It gives an overview and theoretical framework on economic assessments, in comparison with approaches in the USA. The budget is USD 65,000. Prof. F. Rutten is the PI and Dr. Niessen is a senior member of the research team. The project started in 2005 and ended in 2007.
The Dutch National Institute of Public Health (RIVM) funded the project “Integrated Macro-Modeling of Health Prevention and Cure in support of the Dutch National Health Forecast 2006 of the Netherlands. Dr. Niessen has been the PI. It started in 2005-and is still ongoing. The budget is 50,000.
Selected publications
Niessen LW, Hove ten AC*, Hilderink HH, Weber M, Mulholland K , Ezzati M: Comparative impact assessment of child pneumonia interventions. Bull WHO, 2008. In press.
Redekop WK, Orlewska E, Maciejewski : Costs and effects of secondary prevention with perindopril in stable coronary heart disease in Poland - an analysis of the EUROPA Study including 1251 Polish patientsP, Rutten FH, Niessen LW . Pharmacoeconomics. 2008; 26(10):861-77.
Bhatta N*, Dhakal SS, Rizal S, Kralingen KW, Niessen L.: Clinical spectrum of patients presenting with bronchiectasis in Nepal: evidence of linkage between tuberculosis, tobacco smoking and toxic exposure to biomass smoke. KUMJ. 2008; 6(2):195-203.
Baltussen R, Asbroek AHA*, Shrestha N*, Bhattharai P and Niessen LW: A rational multi-criteria approach to priority setting: should a lung health programme be implemented in Nepal? Health Pol Plan 2007; 22(3):178-85.
Bont de A, Zandwijken G, Stolk E, Niessen L. Prioritisation by physicians in the Netherlands--the growth hormone example in drug reimbursement decisions. Health Policy. 2007; 80(3):369-77.
Dirks M*, Niessen LW, Koudstaal PJ, Franke C, van Oostenbrugge RJ, Dippel DWJ: IV thrombolysis in acute ischemic stroke: from trial to clinical indications- an international Delphi study. J Neur Neurs Psych 2007; 78(7):685-9
Dirks M*, Niessen LW, Koudstaal PJ, and Dippel DWJ: Promoting acute thrombolysis for ischaemic stroke (PRACTISE) A cluster randomised controlled trial(ISRCTN 20405426). Int J Stroke. 2007; 2(2):151-9.
Gravelle H, Brouwer Discounting in economic evaluations: stepping forward towards optimal decision rules.W, Niessen LW, PostmaP and Rutten FFH: Health Economics 2007; 16(3):307-17.
Niessen LW, Grijseels E, Koopmanschap M and Rutten FFH: Economic evidence for clinical practice – the case of 31 Dutch consensus guidelines. J Eval Clin Pract. 2007; 13(1):68-78.
Niezen M*, de Bont A, Stolk E, Eyck A, Niessen L, Stoevelaar H. Conditional reimbursement within the Dutch drug policy. Health Policy. 2007; 84(1):39-50.
Teaching Interests
Advisees
Final Oral Participation PhDs (co-promotor)
- Raymond Hutubessy, MSc: Sectoral cost-effectiveness analysis. Promotor: Prof. Frans Rutten. Erasmus University Rotterdam. Defence Nov 20th 2003
- Guus ten Asbroek, MSc, MScEpi: Health services research for health policy. Promoter Prof. Niek Klazinga. University of Amsterdam. Defence: Dec 14th 2006.
- Sameer K.C., MScStat: Multi-state modeling in lung health in developing countries. Promotor: Prof. Frans Willekens and Prof Frans Rutten; University of Groningen. January 2009.
- Naveen Shrestha, MPH, MSc: Syndromic treatment guidelines in primary care - evaluation of WHO’s Practical Approach to Lung Health in Nepal. Promotor: Prof. Frans Rutten. Erasmus University Rotterdam.
- Monica Ortegon, MD, DscEpi: Health technology assessment in chronic diseases. Promotor Frans Rutten. Erasmus University Rotterdam / World Health Organisation, CHOICE project.
- Maaike Dirks, MD: Expanding thrombolysis in acute stroke in the Netherlands in real-life settings. Promotor Peter Koudstaal. Erasmus University Rotterdam. Other co-promoter: Diederik Dippel.
- Loes Schouten, MA: Evaluation of “Breakthrough” initiatives in The Netherlands. Promoters Richard Grol en Robbert Huijsman. University of Nijmegen.
- Anne Kilburg, MSc: Economic evaluation of organ transplantation. Promotor Frans Rutten. Erasmus Rotterdam.
- Amber van der Heijden, MSc: MICADO, an integrated Dutch diabetes model to evaluate integrated diabetes care. Promotor Profs Giel Nijpels en Jacqueline Dekker. VU University, Amsterdam. 2nd co-promotor Caroline Baan, RIVM.
- Dave Cobden, MSc: Patient outcomes in diabetes care (US). Promotor Frans Rutten. Erasmus Rotterdam
Final Oral Participation MSc’s
MSc thesis: main supervisor and committee chair
- Thesis supervisions include clinical epidemiology, public health, health services research, health policy & management, or health economics, and health insurance courses. These are all part of international student MSc courses in English (75% non-Dutch) at Erasmus or elsewhere.
MSc Health Services Research (Netherlands Institute Health Sciences)
- Chiafen Hsu, MA: Costs scenarios in stroke services in the Netherlands. (Taiwan)
- Nicole van Os, MD: Cost-effectiveness analyses of guidelines for DM nephropathy (Nederland/Zimbabwe)
- Aziza Mwisongo, MD: Costs and effects of TB control in Tanzania (Tanzania)
- Prahlad Battarai, MSc: Quality of life measurements in Nepalese lung patients in a rural lowland district. (Nepal)
- Annabelle Slingerland: HbA1c stratified cost-effectiveness analysis of patient-centred implementation of diabetes guidelines. (Netherlands) summer 2006
- Steef Baeten: Long-term cost-effectiveness of integrated stroke care – a disability-stratified analysis. (Netherlands). Summer 2006
MSc Clinical Epidemiology ((Netherlands Institute Health Sciences)
- Narendra Bhatta: Hemoptysis revisted. July 2007. (Nepal)
- Monica Ortegon, MD, Cost-effectiveness of diabetic foot guidelines. September 2003
DSc MSc Clinical Epidemiology (Netherlands Institute Health Sciences)
- Monica Ortegon, MD: Cost-effectiveness analysis in diabetes (Columbia)
MSc thesis: Health Policy and Management (Erasmus U)
- Kyra Edelenbos: Cost-effectiveness of intensive physiotherapy in stroke patients in the Netherlands. Plus: research training Health Policy and Management. (Nederland)
- Leontien Laterveer: Health policy options for enhancing equity in public health expenditure in developing countries – case studies of 23 developing countries. World Bank. (Nederland).
- Caroline Smeenk: Rational Priority Setting in Reproductive Health Funding in 12 countries. NIDI, The Hague/UNFPA. (Nederland)
MSc thesis: Health Economics Policy and Law (Erasmus U)
- Dung Ngo: Weighing of children’s life years in cost-effectiveness analysis. (Nederland/Vietnam)
- Nadia Benhadi: The real life cost-effectiveness analysis of child health interventions in India. (Netherlands/Marocco)
- Anne ten Hove: Cost-effectiveness of cardiovascular risk prevention in Dutch diabetics. (Dutch). Defense summer 2006.
- Claudine de Meijer: Determinants of health care access in India – a MIU-based analysis. India.
- Corinne Eisma. Health care cost of Reproductive Health Services in Yemen, an empirical study. Summer 2007
- Saray …. Patient- and health-system related determinants of re-admissions, a multi-variate regression analysis of the universal health insurance. Thailand.
- Liselore van Ekdom, Country Validation of Child Survival Costs. WHO, Geneva
MSc thesis: Econometrics (Erasmus U; Department of Economics)
- Emil Sanders: Macro-economic consequences of malaria.
MSc Public Health (Netherlands School for Public Health)
- Rimma Shaginian, MD, Reg. Endo: The analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normo-glycemia in the Netherlands. (Georgia/Armenia) Nominated RIVM award. (Ukraine).
MSc Health Economics (University of York)
- Rudolf Schrover: DiabeticNephropathy in Hypertensive NIDDM Patients in The Netherlands: a Cost-Effectiveness Analysis of National Clinical Guidelines . (Nederland)
- Fiona Maciver: Optimal intervention strategies for Dutch hepatitis C patients according to disease genotype: a cost-effectiveness analysis. (Schotland)
Classroom Instruction
Title, Course Enrolment (Principal Instructor)
Quality of Care course module in MSc Health Services Research, Netherlands Institute of Health Sciences, Erasmus graduate school, Erasmus University Rotterdam.
Epidemiology, public health and decision making course module in MSc Health Economics, Policy and Law and/or MSc Health Economics, Department of Health Policy & Management. Erasmus University Rotterdam.
Other Significant Teaching
Primary care in developing countries - clinical and non-clinical courses and course modules for hundreds of health workers in Nepal and Peru. Ministries of Health, local medical schools and training institutes, and international agencies (WHO, UNFPA, UNICEF).
Confluent education in clinical pathology – student-assistantship in teaching medical students after thorough training in small-group dynamics and teaching, Erasmus Medical School.
Economics of Health and Health Care course module in MSc Health Economics, Policy and Law and/or MSc Health Economics, Department of Health Policy & Management. Erasmus University Rotterdam.
Article
Suhrcke, M, Boluarte, TA and Niessen, L (2012) A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries. BMC Public Health, 12 (2).
Dirks, M, Baeten, SA, Dippel, D, Exel, NJA, Wijngaarden, JDA, Koudstaal, PJ and Niessen, LW (2011) Real-life costs and effects of an implementation program to increase thrombolysis in stroke. Neurology. (In Press)
Ekdom van, L, Stenberg, K, Scherpbier, RW and Niessen, LW (2011) Global cost of child survival - estimates from country-level validation. Bulletin WHO, 89 (4). pp. 267-277.
Baeten, SA, Baltussen, R, Bridges, J and Niessen, LW (2010) Incorporating equity-efficiency trade-offs in cost-effectiveness analysis - three approaches applied to breast cancer control. Value in Health, 13 (5). pp. 573-579.
Baeten, SA, Baltussen, R, Uyl-de Groot, C, Bridges, JFP and Niessen, LW (2010) Reducing Disparities in Breast Cancer Survival - the effect of Large-Scale Screening of the Uninsured in the USA. The Breast. (In Press)
Baeten, Stefan A, van Exel, N J A, Dirks, Maaike, Koopmanschap, Marc A, Dippel, Diederik WJ and Niessen, Louis (2010) Lifetime health effects and medical costs of integrated stroke services - a non-randomized controlled cluster-trial based life table approach. Cost Effectiveness and Resource Allocation, 8 (1). p. 21. ISSN 1478-7547
Baltussen, R, Youngkong, S, Paolucci, F and Niessen, LW (2010) Multi-criteria decision analysis to prioritize health interventions: capitalizing on first experiences. Health Policy, 96 (3). pp. 262-264.
Cleveringa, FGW, Welsing, PMJ, Niessen, LW, Rutten, GEHM and Redekop, WK (2010) Cost-effectiveness of the Diabetes Care Protocol, a multifaceted computerized decision support diabetes management intervention that reduces cardiovascular risk. Diabetes Care, 33 (2). pp. 258-263. ISSN 0149-5992
Cobden, DS, Niessen, L, Rutten, FF and Redekop, WK (2010) Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach. Patient preference and adherence, 4. pp. 283-290.
Fairall, Lara, Bachmann, Max, Zwarenstein, Merrick, Bateman, Eric D., Niessen, Louis, Lombard, Carl, Majara, Bosielo, English, René, Bheekie, Angeni, van Rensburg, Dingie, Mayers, Pat, Peters, Annatjie and Chapman, Ronald (2010) Cost-effectiveness of educational outreach to primary care nurses to increase tuberculosis case detection and improve respiratory care: economic evaluation alongside a randomised trial. Tropical Medicine & International Health, 15 (3). pp. 277-286. ISSN 13602276
Schouten, LMT, Niessen, LW, van de Pas, JWAM, Grol, RPTM and Hulscher, MEJL (2010) Cost-Effectiveness of a Quality Improvement Collaborative Focusing on Patients With Diabetes. Medical Care, 48 (10). pp. 884-891. ISSN 0025-7079
Bosch, M, Weijden van der, T, Grol, R, Schers, H, Niessen, LW and Wensing, M (2009) Structured chronic primary care and health-related quality of life in chronic heart failure. BMC Health Services Research, 9 (1). p. 104.
Cobden, DB, Niessen, LW, Barr, CE, Rutten, F and Redekop, WK (2009) Relationships among self-management, patient perceptions of care, and health economic outcomes for decision-making and clinical practice in type 2 diabetes. Value in Health, 13 (1). pp. 138-147.
Jansink, R, Braspenning, J, Weijden van der, T, Niessen, LW and Wensing, M (2009) Nurse-led motivational interviewing to change the lifestyle of patients with type-2 diabetes (MILD-project): protocol for a cluster, randomized, controlled trial on implementing lifestyle reccommendations. BMC Health Services Research, 9 (1). p. 19.
Niessen, LW, Hoveton, AC, Hilderink, HH, Weber, M, Mulholland, K and Ezzati, M (2009) Comparative impact assessment of child pneumonia interventions. Bulletin of the World Health Organisation, 87 (6). pp. 472-478.
van Wijngaarden, J, Dirks, M, Fabricotti, I, Huijsman, R, Niessen, LW and Dippel, D (2009) Hospital rates of thrombolysis for acute ischaemic stroke; the influence of organizational culture. Stroke, 40 (10). pp. 3390-3392.
van der Heijden , A, Ortegon, M, Niessen, LW, Nijpels, G and Dekker, JM (2009) Prediction of coronary heart disease in general, pre-diabetic and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE and UKPDS risk functions - the Hoorn Study. Diabetes Care, 32 (11). pp. 2094-2098.
Bhatta, N, Dhakal, SS, Rizal, S, Kralingen, KW and Niessen, LW (2008) Clinical specturm of patients presenting with bronchiectasis in Nepal: evidence of linkage between tuberculosis, tobacco smoking and toxic exposure to biomass smoke. Kathmandu Univ Med J, 6 (2). pp. 195-203.
Redekop, WK, Orlewska, E, Maciejewski, P, Rutten, F and Niessen, LW (2008) Costs and effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland - an Analysis of the EUROPA Study Including 1251 Polish Patients. Pharmacoeconomics, 26 (10). pp. 861-877.
Baltussen, R, ten Asbroek, A H A, Koolman, X, Shrestha, N, Bhattarai, P and Niessen, Louis (2007) Priority setting using multiple criteria: should a lung health programme be implemented in Nepal? Health Policy and Planning, 22 (3). pp. 178-185. ISSN 0268-1080
Dirks, M, Niessen, LW and Huijsman, R (2007) Promoting acute thrombolysis for ischaemic stroke (PRACTISE): Protocol for a cluster of randomized controlled trial to assess the effect of implementation strategies on the rate and effects of thrombolysis for acute ischaemic stoke (ISRCTN 20405426). Int J Stroke, 2 (2). pp. 151-159.
Dirks, M, Niessen, LW, Koudstaal, PJ, Franke, C, van Oostenbrugge, RJ and Dippel, D (2007) Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study. J Neurol Neurosurg Psychiatry, 78 (7). pp. 685-689.
Gravelle, H, Brouwer, W, Niessen, LW, Postma, P and Rutten, F (2007) Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Economics, 16 (3). pp. 307-317.
Niessen, LW, Grijseels, E, Koopmanschap, M and Rutten, F (2007) Economic evidence for clinical practice - the case of 31 Dutch consensus guidelines. Journal of Evaluation and clinical Practice, 13 (1). pp. 68-78.
Niezen, M, Pomp, M, Brouwer, W, de Bont, A, Stolk, E, Eyck, A, Niessen, LW, Koopmanschap, M, Hakkaart, L, van Dijk, WM and Stoevelaar, H (2007) Conditional reimbursement within the Dutch drug policy. Health Policy, 84 (1). pp. 39-50.
Baltussen, Rob and Niessen, Louis (2006) Priority Setting of health interventions: the need for multi-criteria decision analysis. Cost Effectiveness and Resource Allocation, 4 (1). p. 14. ISSN 14787547
Shrestha, Naveen, Samir, K. C., Baltussen, Rob, Kafle, Kumud K., Bishai, David and Niessen, Louis (2006) Practical Approach to Lung Health in Nepal: better prescribing and reduction of cost. Tropical Medicine and International Health, 11 (5). pp. 765-772. ISSN 1360-2276
van Etten, Geert, Baltussen, Rob, Bijlmakers, Leon and Niessen, Louis (2006) Editorial: Advancing the Mexico agenda for health systems research – from clinical efficacy to population health. Tropical Medicine and International Health, 11 (8). pp. 1145-1146. ISSN 1360-2276
van Wijngaarden, J.D.H., Dirks, M, Dippel, D.W., Minkman, M and Niessen, L (2006) Towards effective and efficient care pathways: thrombolysis in acute ischaemic stroke. QJM, 99 (4). pp. 267-272. ISSN 1460-2725
Baltussen, Rob, Brouwer, Werner and Niessen, Louis (2005) Cost-effectiveness analysis for priority setting in health: Penny-wise but pound-foolish. International Journal of Technology Assessment in Health Care, 21 (04). ISSN 0266-4623
Ortegon, Monica Maria, Redekop, William Ken and Niessen, Louis (2004) Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. Diabetes care, 27 (4). pp. 901-7. ISSN 0149-5992
Redekop, W K, Koopmanschap, M A, Rutten, G E H M, Wolffenbuttel, B H R, Stolk, R P and Niessen, L W (2002) Resource consumption and costs in Dutch patients with type 2 diabetes mellitus. Results from 29 general practices. Diabetic medicine : a journal of the British Diabetic Association, 19 (3). pp. 246-53. ISSN 0742-3071
Redekop, W Ken, Koopmanschap, Marc A, Stolk, Ronald P, Rutten, Guy E H M, Wolffenbuttel, Bruce H R and Niessen, Louis (2002) Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes care, 25 (3). pp. 458-63. ISSN 0149-5992
Monograph
Suhrcke, M, Goryakin, Y, Jarrett, J and Niessen, L (2010) Value for money in health finance mechanisms: a review of the evidence and a conceptual framework applied to the AMFm. Research Report. UNSPECIFIED.
Niessen, LW iMTA report, Erasmus University Rotterdam. Evaluation Report to National Health Insurance Board. 'Cost-effectiveness of Entecavir as Antiviral therapy in Hepatitis.'. Research Report. UNSPECIFIED.
Pomp, M, Brouwer, W, van Dijk, WM, Hakkaart, L, Koopmanschap, M, Niessen, LW and Rutten, F Medical technology, health expenditures and welfare. Central planning Bureau, The Hague, Netherlands. Monograph. Research Report. UNSPECIFIED.
Suhrcke, M, Boluarte, TA and Niessen, LW A shortened systematic review of economic evaluations of interventions to combat cardiovascular disease in low- and middle-income countries. (Report prepared for the Institute of Medicine, Washington DC). Research Report. UNSPECIFIED. (Unpublished)
External Activities and Indicators of Esteem
- Member Executive Board, Institute of Medical Technology Assessment
- Member ErasmusMC / Erasmus Medical School Research and Education Committee. 1976- 1980 and 2000-2005.
- Member of the Executive Board, Medical School, 1979-1980.
- Member of the Erasmus Delegation, Medicine Section, National University Council. 1979-1980.
- Member of the Dutch Platform of Health Systems Research. 2007—present
Administrative Posts/Responsibilities
- President of the Board, Dutch Society Tropical Medicine and International Health; chair working parties. 2001-2007.
- Chair Centennial Committee, 2007. Dutch Society of International Health.
- Member Dutch Royal Society of Medicine. 1982- .
- Member of British Society of Tropical Medicine and Hygiene. 1985-1992.
- Chair, Dutch Commission on the Revision of Diabetes Guidelines. 1998-2001
- Chair, Dutch Commission on the Revision of Stroke Guidelines. 1998-2003
- President of the Board, Dutch Society Tropical Medicine and International Health; chair working parties. 2001-2007.
- Chair, National Working Party, Coalition for Health Systems Research, 2004-2006.
- Steering group member, Temporary Working Group, Coalition Global Health Policy and Health Systems Research, 2006-2007.
- Founding Member, Netherlands Platform Global Health Policy and Health Systems Research, 2007- .
- DANIDA, Dutch Royal Tropical Institute Mission on the Evaluation of District Health Programs in Madya Pradesh, India
